JP2015526452A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526452A5
JP2015526452A5 JP2015527878A JP2015527878A JP2015526452A5 JP 2015526452 A5 JP2015526452 A5 JP 2015526452A5 JP 2015527878 A JP2015527878 A JP 2015527878A JP 2015527878 A JP2015527878 A JP 2015527878A JP 2015526452 A5 JP2015526452 A5 JP 2015526452A5
Authority
JP
Japan
Prior art keywords
tetrazol
tetrahydro
cyclohepta
pyridine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527878A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526452A (ja
JP6258937B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/067220 external-priority patent/WO2014029723A1/en
Publication of JP2015526452A publication Critical patent/JP2015526452A/ja
Publication of JP2015526452A5 publication Critical patent/JP2015526452A5/ja
Application granted granted Critical
Publication of JP6258937B2 publication Critical patent/JP6258937B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527878A 2012-08-24 2013-08-19 新規二環式ピリジン誘導体 Expired - Fee Related JP6258937B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12181739.9 2012-08-24
EP12181739 2012-08-24
PCT/EP2013/067220 WO2014029723A1 (en) 2012-08-24 2013-08-19 New bicyclicpyridine derivatives

Publications (3)

Publication Number Publication Date
JP2015526452A JP2015526452A (ja) 2015-09-10
JP2015526452A5 true JP2015526452A5 (https=) 2016-10-06
JP6258937B2 JP6258937B2 (ja) 2018-01-10

Family

ID=46851316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015527878A Expired - Fee Related JP6258937B2 (ja) 2012-08-24 2013-08-19 新規二環式ピリジン誘導体

Country Status (13)

Country Link
US (1) US9562052B2 (https=)
EP (1) EP2888245B1 (https=)
JP (1) JP6258937B2 (https=)
KR (1) KR20150046056A (https=)
CN (1) CN104583197B (https=)
AR (1) AR092223A1 (https=)
BR (1) BR112015002950A2 (https=)
CA (1) CA2873295A1 (https=)
ES (1) ES2596243T3 (https=)
MX (1) MX2015001099A (https=)
RU (1) RU2648247C2 (https=)
TW (1) TWI614237B (https=)
WO (1) WO2014029723A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309250B2 (en) 2011-06-22 2016-04-12 Vertex Pharmaceuticals Incorporated Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
SI2941432T1 (en) 2012-12-07 2018-07-31 Vertex Pharmaceuticals Incorporated 2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
EP2970288A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2014143240A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
US8957078B2 (en) 2013-03-15 2015-02-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
PT3077397T (pt) 2013-12-06 2020-01-22 Vertex Pharma Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo
MX373102B (es) 2014-06-05 2020-04-17 Vertex Pharma Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de ataxia telangiectasia mutada y rad3 relacionado (atr) cinasa, preparación de tal compuesto y diferentes formas sólidas del mismo.
SG11201610500WA (en) 2014-06-17 2017-01-27 Vertex Pharma Method for treating cancer using a combination of chk1 and atr inhibitors
AU2016331955B2 (en) 2015-09-30 2022-07-21 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
CN107556309B (zh) * 2017-09-11 2020-12-01 浙江永宁药业股份有限公司 多取代四氢萘啶类化合物的药物用途及其制备方法
CN107540672A (zh) * 2017-10-10 2018-01-05 牡丹江医学院 一种治疗肝硬化的药物及其合成方法
JP2023532888A (ja) 2020-06-27 2023-08-01 クレセンタ バイオサイエンシズ 細胞代謝を調節する化合物の組成及び使用方法
KR102889668B1 (ko) * 2020-11-03 2025-11-24 주식회사 엘지화학 작물보호제용 신규 화합물
CN116829524A (zh) * 2021-01-06 2023-09-29 中外制药株式会社 酸性官能团的烷基化方法
US12054486B2 (en) 2021-09-24 2024-08-06 Xenon Pharmaceuticals Inc. Pyridine derivatives and their use as sodium channel activators
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds
CN114907372B (zh) * 2022-04-26 2023-07-04 黑龙江中医药大学 一种用于治疗多囊卵巢综合征的药物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232013B (https=) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
NO940245D0 (no) * 1993-01-28 1994-01-24 Takeda Chemical Industries Ltd Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
ATE188377T1 (de) * 1993-06-29 2000-01-15 Takeda Chemical Industries Ltd Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
AR008789A1 (es) * 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
TW477787B (en) * 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline
JP4473698B2 (ja) * 2003-10-31 2010-06-02 武田薬品工業株式会社 ピリジン化合物
US7521557B2 (en) * 2005-05-20 2009-04-21 Bristol-Myers Squibb Company Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
JO3077B1 (ar) * 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
US7994321B2 (en) * 2006-08-08 2011-08-09 Hoffmann-La Roche Inc. Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives
JP2010510317A (ja) * 2006-11-20 2010-04-02 ブリストル−マイヤーズ スクイブ カンパニー ジペプチジルペプチダーゼivの阻害剤としての7,8−ジヒドロ−1,6−ナフチリジン−5(6h)−オンおよび関連二環式化合物、および方法
CN101245062A (zh) * 2007-02-16 2008-08-20 中国科学院上海药物研究所 四氢喹啉类化合物、其制备方法及药物组合物
WO2010056631A1 (en) * 2008-11-12 2010-05-20 Schering Corporation Inhibitors of fatty acid binding protein (fabp)
US8889683B2 (en) * 2010-09-27 2014-11-18 Merck Sharp & Dohme Corp. Substituted quinoxalines as inhibitors of fatty acid binding protein
CN103906735B (zh) * 2011-11-04 2016-12-07 霍夫曼-拉罗奇有限公司 新芳基-喹啉衍生物

Similar Documents

Publication Publication Date Title
JP2015526452A5 (https=)
RU2015107979A (ru) Новые бициклические производные пиридина
JP2010524974A5 (https=)
AU2013329552B2 (en) 5-phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors
JP2010524970A5 (https=)
JP2016500073A5 (https=)
JP2007504148A5 (https=)
JP2015500332A5 (https=)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2013527173A5 (https=)
JP2013508404A5 (https=)
JP2013528591A5 (https=)
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2013525498A5 (https=)
EP2146716A1 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
HRP20130054T1 (hr) Spojevi pirazina kao inhibitori fosfodiesteraze 10
JP2012508776A5 (https=)
JP2017502049A5 (https=)
JP2016514718A5 (https=)
CA2798622A1 (en) Indoles
JP2010506850A5 (https=)
JP2017530960A5 (https=)
CA2351725A1 (en) Substituted pyrazoles as p38 kinase inhibitors
JP2019514878A5 (https=)